Table 1

Flowchart of patient follow-up

ScreeningInclusion D0Study periodDeath/30 daysFollow-up 6 months
Baseline information
 Demographic data and history
 Inclusion and exclusion criteria
 Written informed consent
 Diagnosis and focus of infection
 Vital signs
 APACHEII/SOFA√D1, 3, 7
Efficacy observation
 Cardiac function assessment (CI, LVEF)√D1, 3, 5, 7, 10, 14
 ECMO intervention
 Treatment with vesopressor
 Mechanical ventilation
 CRRT implication
 Laboratory tests√D1, 3, 5, 7
Safety observation
 Complications of ECMO
 Adverse event
Additional observation
 ICU and hospital LOS
 Alive or dead status
 Life quality (EQ-5D score)
  • APACHEII, Acute Physiology and Chronic Health Evaluation II; CI, cardiac index; CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation; LOS, length of stay; SOFA, Sequential Organ Failure Assessment.